These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21980542)

  • 1. Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
    Perry MR; Wyllie S; Prajapati VK; Feldmann J; Sundar S; Boelaert M; Fairlamb AH
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1227. PubMed ID: 21980542
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
    Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent.
    Imamura H; Downing T; Van den Broeck F; Sanders MJ; Rijal S; Sundar S; Mannaert A; Vanaerschot M; Berg M; De Muylder G; Dumetz F; Cuypers B; Maes I; Domagalska M; Decuypere S; Rai K; Uranw S; Bhattarai NR; Khanal B; Prajapati VK; Sharma S; Stark O; Schönian G; De Koning HP; Settimo L; Vanhollebeke B; Roy S; Ostyn B; Boelaert M; Maes L; Berriman M; Dujardin JC; Cotton JA
    Elife; 2016 Mar; 5():. PubMed ID: 27003289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.
    Stauch A; Duerr HP; Dujardin JC; Vanaerschot M; Sundar S; Eichner M
    PLoS Negl Trop Dis; 2012; 6(12):e1973. PubMed ID: 23285309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.
    Perry MR; Wyllie S; Raab A; Feldmann J; Fairlamb AH
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19932-7. PubMed ID: 24167266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
    Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantum.
    Rojo D; Canuto GA; Castilho-Martins EA; Tavares MF; Barbas C; López-Gonzálvez Á; Rivas L
    PLoS One; 2015; 10(7):e0130675. PubMed ID: 26161866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar.
    Khanra S; Sarraf NR; Das S; Das AK; Roy S; Manna M
    Acta Trop; 2016 Dec; 164():177-184. PubMed ID: 27629023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
    Kothari H; Kumar P; Sundar S; Singh N
    Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.
    Ashutosh ; Garg M; Sundar S; Duncan R; Nakhasi HL; Goyal N
    Antimicrob Agents Chemother; 2012 Jan; 56(1):518-25. PubMed ID: 22064540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates.
    Wyllie S; Mandal G; Singh N; Sundar S; Fairlamb AH; Chatterjee M
    Mol Biochem Parasitol; 2010 Oct; 173(2):162-4. PubMed ID: 20553768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Das AK; Roy S
    PLoS Negl Trop Dis; 2012; 6(12):e1987. PubMed ID: 23301108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
    Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
    Kumar D; Kulshrestha A; Singh R; Salotra P
    Antimicrob Agents Chemother; 2009 Feb; 53(2):835-8. PubMed ID: 19015344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
    Thakur CP; Dedet JP; Narain S; Pratlong F
    Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani.
    Potvin JE; Leprohon P; Queffeulou M; Sundar S; Ouellette M
    Clin Infect Dis; 2021 May; 72(10):e526-e532. PubMed ID: 32827255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.